fml liquifilm augentropfensuspension
abbvie ag - fluorometholonum - augentropfensuspension - fluorometholonum 1 mg, benzalkonii chloridum 40 µg, poly(alcohol vinylicus), dinatrii edetas, natrii chloridum, natrii dihydrogenophosphas monohydricus et dinatrii phosphas heptahydricus corresp. phosphas 1.91 mg, polysorbatum 80, natrii hydroxidum ad ph, aqua purificata, ad suspensionem pro 1 ml. - non infetto infiammazione agli occhi - synthetika
ultralan dermatologico
karo pharma ab - fluocortolone - fluocortolone
ultraproct
karo healthcare ab - fluocortolone - fluocortolone
fluaton
bausch & lomb-iom s.p.a. - fluorometolone - fluorometolone
serekis
karo healthcare ab - fluocortolone - fluocortolone
doloproct
karo healthcare ab - fluocortolone - fluocortolone
flumetol
thea farma s.p.a. - fluorometolone - fluorometolone
flarex
immedica pharma ab - fluorometolone - fluorometolone
redoff
thea farma s.p.a. - fluorometolone e midriatici - fluorometolone e midriatici
fml-neo liquifilm augentropfensuspension
abbvie ag - fluorometholonum, neomycinum - augentropfensuspension - fluorometholonum 1 mg, neomycinum 3.5 mg ut neomycini sulfas, benzalkonii chloridum 0.04 mg, poly(alcohol vinylicus), dinatrii edetas, natrii chloridum, dinatrii phosphas heptahydricus corresp. phosphas 1.89 mg, polysorbatum 80, natrii hydroxidum aut acidum hydrochloridum, aqua purificata, natrii thiosulfas, ad suspensionem pro 1 ml. - infetti infiammazione agli occhi - synthetika